Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208011 · ClinicalTrials.gov registry record
A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes
A clinical trial, sponsored by Louisiana State University, Baton Rouge.
- Completed
- Registry status
- 140
- Enrollment target
NCT02208011 is a clinical trial that has completed, run by Louisiana State University, Baton Rouge. The registered enrollment target is 140 participants.
The verdict
NCT02208011 has completed, sponsored by Louisiana State University, Baton Rouge.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery. Inclusion Criteria: * English speaking * pregnant woman \>15 weeks gestation undergoing an exam for ruptured membranes Exclusion Criteria: * Known placental previa * Active vaginal bleeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208011
The ClinicalTrials.gov registry entry for NCT02208011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University, Baton Rouge, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02208011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208011 about?
NCT02208011 is a clinical study titled "A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes". Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery. Inclusion Criteria: * English speaking * pregnant woman \>15 weeks gestation undergoing an exam...
What is the current status of trial NCT02208011?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2014-08. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02208011?
This trial is sponsored by Louisiana State University, Baton Rouge, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.